A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine

Summary

This prospective annual release study was designed to assess the safety of a trivalent influenza virus vaccine using a new strain recommended for the 2008-2009 influenza season not previously contained in the trivalent intranasal FluMist vaccine. Three hundred healthy adults received a single dose of vaccine or placebo and were followed for 180 days.

Timeline

Start

2008-06

Primary completion

2008-07

Completion

2008-12

Drugs

Indications